You are viewing: North America Structural Heart Devices Market analysis

The North America Structural Heart Devices Market was valued at $5995.9 Million in 2024 and projected to reach to $9635.2 Million by 2029, representing a compound annual growth rate of 10.0%. North America's structural heart devices market is poised for sustained expansion through 2029, driven by demographic shifts toward an aging population with higher prevalence of structural cardiac conditions.

North America Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Structural Heart Devices Market Trends and Insights

  • This 10.0% compound annual growth rate reflects North America's leadership in advanced cardiac interventions, driven by aging demographics, rising prevalence of structural heart disease, and strong healthcare infrastructure.
  • North America benefits from high adoption rates of minimally invasive procedures and substantial investment in cardiac innovation. The North America market is characterized by strong regulatory frameworks, established reimbursement pathways, and a concentration of leading medical device manufacturers.
  • North America's healthcare systems prioritize early diagnosis and intervention for conditions such as atrial fibrillation, mitral regurgitation, and aortic stenosis, supporting sustained demand for structural heart solutions.
  • Between 2024 and 2029, North America is expected to maintain its position as a key growth engine, supported by clinical evidence, physician expertise, and patient awareness initiatives..

Key Market Statistics

  • CAGR (2024-2029) 10.0% CAGR
  • Market Size, 2024 ~USD 5995.9 Million
  • Forecast, 2029 ~USD 9635.2 Million
  • Geography North America

North America Structural Heart Devices Market Overview

Market Leadership Position :

North America commands the largest share of the global structural heart devices market, valued at $5,995.9 million in 2024, driven by advanced healthcare infrastructure, high adoption rates of innovative cardiac interventions, and strong reimbursement policies across the US and Canada.

Aging Population Dynamics :

North America's rapidly aging demographic profile significantly fuels demand for structural heart devices. The region's elderly population faces elevated incidence of atrial fibrillation, mitral valve disease, and aortic stenosis, creating sustained market expansion opportunities through 2029.

Robust 10% CAGR Growth :

The North American market is projected to grow at 10.0% CAGR from 2024 to 2029, outpacing the global average of 9.5%. This accelerated growth reflects increasing procedural volumes, expanding patient access, and continuous technological innovations in minimally invasive cardiac solutions.

Strong Healthcare Infrastructure :

North America's well-established healthcare system, coupled with high healthcare spending, advanced cardiac centers, and skilled interventional cardiologists, enables rapid adoption of cutting-edge structural heart devices and supports market growth to $9,635.2 million by 2029.

North America Structural Heart Devices Market Dynamics

  • The region's advanced healthcare infrastructure, robust reimbursement landscape, and strong physician adoption of minimally invasive interventions create a favorable environment for market growth.
  • Technological innovations in transcatheter solutions and improved patient outcomes continue to expand the addressable patient population. The market's 10% CAGR trajectory reflects increasing procedural volumes across major cardiac centers and growing patient awareness of structural heart disease treatment options.
  • North America's leadership in clinical research and device development ensures continuous innovation, while favorable regulatory pathways accelerate product launches.
  • Strategic investments by major medical device manufacturers and expanding indications for existing therapies will further propel market expansion through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's structural heart devices market is valued at $5,995.9 million in 2024 and will reach $9,635.2 million by 2029, representing a 10.0% CAGR.
    • North America leads in adoption of minimally invasive structural heart interventions due to advanced healthcare infrastructure and strong reimbursement coverage.
    • Aging population and rising prevalence of atrial fibrillation and valvular disease are primary growth drivers in North America.
    • North America's regulatory environment and established clinical pathways support rapid innovation and market expansion through 2029.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    North America Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    Target Audience

    • Medical Device Manufacturers : Strategic planning and market entry decisions require detailed North American market sizing, growth projections, and country-specific data to optimize product launches, manufacturing capacity, and sales force allocation.
    • Healthcare Investors & PE Firms : Investment thesis development and portfolio company valuations depend on accurate North American market data, growth trajectories, and regional dynamics to assess returns and identify acquisition targets in structural heart devices.
    • Hospital & Healthcare Systems : Procurement and capital budgeting decisions require understanding North American market trends, device adoption rates, and regional pricing to optimize inventory management and negotiate favorable supplier contracts.
    • Regulatory & Market Access Professionals : Navigating North American regulatory pathways and reimbursement strategies requires region-specific market intelligence, competitive landscape analysis, and country-level insights for successful product commercialization.
    • Cardiologists & Clinical Leaders : Evidence-based practice and institutional planning require current market data on device availability, clinical adoption trends, and regional innovations to guide treatment protocols and technology investments.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 7398.8 Million · 9% wtd CAGR ·
    Asia Pacific
    ~USD 6116.2 Million · 10.2% wtd CAGR ·
    Latin America
    ~USD 1659.2 Million · 7.8% wtd CAGR ·
    Middle East & Africa
    ~USD 883.2 Million · 7.7% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 4243.3 Million
    CanadaUSD 985.8 Million

    Country market size visualization

    US
    USD 4243.3 Million
    Canada
    USD 985.8 Million

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation for North America at $5,995.9M (2024) with detailed forecasts to $9,635.2M (2029), enabling accurate financial planning and investment decisions specific to this high-growth region.
    • Country-Level Granularity : Access detailed market breakdowns for US ($4,243.3M) and Canada ($985.8M), allowing targeted market entry strategies and resource allocation based on individual country dynamics and growth potential.
    • Competitive Intelligence : Understand North America's market leadership position relative to global markets, identify competitive advantages, and benchmark performance against the 9.5% global CAGR to inform strategic positioning.
    • Demographic & Clinical Insights : Leverage region-specific data on aging populations, disease prevalence, and healthcare infrastructure to identify growth drivers, unmet clinical needs, and opportunities for product development and market expansion.
    • Regulatory & Reimbursement Context : Gain insights into North America's favorable regulatory environment and reimbursement landscape that accelerate device adoption, enabling informed go-to-market strategies and pricing optimization for structural heart solutions.

    Frequently asked questions

    What is the current size of the structural heart devices market in North America?

    North America's structural heart devices market was valued at $5,995.9 million in 2024 and is expected to grow to $9,635.2 million by 2029.

    What is the projected growth rate for North America's structural heart devices market?

    North America's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2029.

    What factors are driving growth in North America's structural heart devices market?

    Key drivers in North America include an aging population, rising prevalence of structural heart conditions, strong healthcare infrastructure, high adoption of minimally invasive procedures, and established reimbursement pathways.

    Which structural heart conditions are most prevalent in North America?

    North America experiences high prevalence of atrial fibrillation, mitral regurgitation, aortic stenosis, and other valvular diseases, driving demand for structural heart interventions.

    How does North America's market compare to global structural heart devices growth?

    North America's 10.0% CAGR outpaces the global market CAGR of 9.5%, reflecting North America's advanced healthcare systems and higher adoption rates of structural heart interventions.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status